Descrição: As doenças causadas por actinomicetos patógenos, aeróbios e anaeróbios facultativos, diferem consideravelmente no que diz respeito à sua etiologia, patogênese, apresentação clínica e epidemiologia. Objetivos: Analisar a distribuição etária, manifestações clínicas, doenças de base e condições associadas, achados radiológicos, microbiológicos, tratamento e evolução, nos pacientes com actinomicetoses (actinomicose, nocardiose, rodococose). Delineamento: Foram analisados, retrospectivamente, prontuários de pacientes com achados microbiológicos positivos para infecções por actinomicetos. Local do estudo: Um hospital universitário de atendimento terciário em Porto Alegre, Rio Grande do Sul, Brasil. Pacientes e métodos: Foram incluídos neste estudo, pacientes com diagnóstico de actinomicose, nocardiose e rodococose, num período de 1978 a 2009. Os critérios microscópicos para o diagnóstico de actinomicetose foram os seguintes: actinomicose - composto por grânulos actinomicóticos, filamentos Gram-positivos, não ácido-resistentes; nocardiose - bactérias filamentosas ramificadas, Gram-positivas, e ácido-resistentes; rodococose - cocobacilos Gram-positivos, ácido resistentes. Resultados: Foram incluídos 59 pacientes com actinomicetose. Actinomicose foi obervada em 27 pacientes entre 8 e 65 anos (idade média de 39,9 anos), 22 do sexo masculino (81,5%). Doença oral (cárie dentária, a doença periodontal) esteve frequentemente associada, sendo procedimento odontológico o fator de risco mais importante. A apresentação clínica foi actinomicose torácica em 24 casos, em dois facial e em um cérvico-facial e mediastinal. O diagnóstico microscópico foi positivo em 25, com o isolamento do organismo em cultivo anaeróbico em um, e, pelo teste de imunofluorescência direta em um. Estes dois últimos casos foi identificado como A. israelii. O tratamento mais utilizado consiste na administração prolongada de penicilina e esteve associado a boa evolução na maioria dos casos. Nocardiose foi observada em 27 pacientes, a idade variou entre 21 e 84 anos, idade média de 51,8 anos. A manifestação mais comum foi pneumonia cavitária, apresentado no paciente imunossuprimido, especialmente recebendo altas doses de corticoterapia. Todos os casos foram positivos para filamentos bacterianos ramificados Gram-positivos, ácido resistentes, sugestivos de espécies de Nocardia. Nocardia sp foi isolada em 14 casos, ―N. asteroides” em 7, N. farcinica em 2, N. brasiliensis em 1, N. pseudobrasiliensis em 1, N. abscessus em 1 e N. cyriacigeorgica em 1. Doze pacientes foram a óbito e os restantes tiveram melhora clínica. A rodococose foi diagnosticada em 5 pacientes, com idade, no momento do diagnóstico, de 22-69 anos (média de 45,6). Rhodococcus foi isolado em todos os 5 casos, três pacientes imunodeprimidos apresentaram infecção pulmonar pelo R. equi. O caso do paciente com HIV/AIDS foi fatal. Conclusões: Esta experiência, indica que a informação clínica associada ao Gram e a ácido-resistência em amostras clínicas é útil no reconhecimento da infecção por actinomicetos. A actinomicetose deve ser sempre considerada em pacientes apresentando doença febril supurativa ou radiografia de tórax anormal, em paciente com estado imune alterado causado por determinadas drogas (corticoterapia) e condições associadas (HIV/AIDS). / Background: Diseases caused by pathogenic aerobic and facultative anaerobic actinomycetes differ considerably with respect to their etiology, pathogenesis, clinical appearence and epidemiology. Objectives: To analyse the age distribution, clinical manifestations, underlying diseases and associated medical conditions, radiographic findings, microbiology, treatment and outcome, in patients with actinomycetosis (actinomycosis, nocardiosis, rhodococcosis). Design: The medical records of patients with positive microbiology findings to actinomycetes infections were retrospectively analysed. Settings: A university-based tertiary care hospital in Porto Alegre, Rio Grande do Sul, Brazil. Patients and methods: From 1978 through 2009 patients diagnosed with actinomycosis, nocardiosis, and rhodococcosis were included in this study. The microscopic criteria for diagnosis of actinomycetosis were as follow: actinomycosis –granules composed by branching Gram-positive organisms non acid-fast stained; nocardiosis - branched filamentous, Gram-positive, and acid-fast bacteria; rhodococcosis - coccobacilli Gram-positive, and acid-fast organism. Results: Sixty-five patients with actinomycetosis were included. Actinomycosis was oberved in 27 patients between 8 and 65 years old (mean age, 39,9 years), 22 were male (81,5%). Oral disease (poor dentition, periodontal disease) frequently associated with dental procedure was the most important risk factor. The clinical presentation was thoracic actinomycosis in 24 cases, facial in two, and cervico-facial and mediastinal one. Microcopic diagnosis were positive in 25, recovery of organism in anaerobic culture in one, and by fluorescent antibody test in one. These last two cases was identified as A. israelii. Treatment most commonly consisted of prolonged administration of penicillin and was associated with good outcome in the majority of cases. Nocardiosis was observed in 27 patients, aged 21 to 84 years old, with a mean age of 51,8 years. Cavitary pneumonia was the most common manifestation, presented in immunosuppresed patient, especially receiving high-dose corticotherapy. All cases were positive for branching Gram-positive, acid-fast bacterial filaments, suggestive of a Nocardia species. Nocardia sp was isolated in 14 cases, ―N. asteroides” in 7, N. farcinica in 2, N. brasiliensis in 1, N. pseudobrasiliensis in 1, N. abscessus in 1 and N. cyriacigeorgica in 1. Twelve patients died and the remaining cases were well improved. The diagnosis of rhodococcosis was made in five patients, ranged in age at time of diagnosis from 22 to 69 years, with a mean age of 45,6 years. Rhodococcus was isolated in all 5 cases, three immunocompromised patients showed pulmonary infection by R. equi. The case with HIV/AIDS was fatal. Conclusions: This experience, indicates that clinical information with Gram and acid-fast stains on clinical specimens is helpful in recognizing the possibility os actinomycetes should always be considered as a cause os suppurative febrile illness or abnormal chest roentgenograms in patient who may have an altered immune status caused by certain drugs (corticotherapy) and underlying conditions (HIV/AIDS).

Actinomycosis is an infrequent bacterial infection involving Actinomyces spp and related organisms which may occur at many body sites. It can also be found in the microbiota. Actinomyces spp are described as gram-positive bacilli whereas some species grow strictly anaerobically and some facultative. Culturing is a standardized method when suspecting actinomycosis and can be a diagnostic challenge because of inhibition of microbiota and slow growth. Enriched agar plates are used when culturing fastidious bacteria and may be more selective when including antibiotics. The aim of this project was to evaluate if using antibiotic disc facilitates identification of Actinomyces spp when mixed with microbiota. A mix of microbiota was made by pooling together several species. The susceptibility of different isolates and microbiota was analysed using antibiotic discs to determine which disc to use in a trial. A trial was done by inoculating the isolates with the microbiota on agar plates, dispensing ciprofloxacin, and trimethoprim discs. A control group without antibiotic discs were also tested. Results showed variance for most isolates susceptibility. No disc performed superior in the trial, but ciprofloxacin on FAA plates incubated anaerobically gave slightly higher recovery. Both discs facilitated identification of some isolates by supressing much microbiota. Considering that the isolates had varying susceptibility it may be problematic to find one common disc. This study has given new insights on what may facilitate identification. Further studies are needed to determine if antibiotic discs could facilitate identification of Actinomyces and needs testing on clinical samples using larger sample size.